No headlines found.
Globe Newswire (Thu, 12-Mar 7:00 AM ET)
Globe Newswire (Thu, 12-Mar 6:30 AM ET)
Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum
Globe Newswire (Tue, 10-Mar 4:45 PM ET)
Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference
Globe Newswire (Thu, 26-Feb 4:15 PM ET)
Globe Newswire (Tue, 24-Feb 4:15 PM ET)
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Thu, 12-Feb 4:15 PM ET)
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
Rapid Micro Biosystems - Class A trades on the NASDAQ stock market under the symbol RPID.
As of April 20, 2026, RPID stock price declined to $2.25 with 163,502 million shares trading.
RPID has a beta of 1.20, meaning it tends to be more sensitive to market movements. RPID has a correlation of 0.04 to the broad based SPY ETF.
RPID has a market cap of $102.98 million. This is considered a Micro Cap stock.
Last quarter Rapid Micro Biosystems - Class A reported $11 million in Revenue and -$.28 earnings per share. This beat revenue expectation by $348,670 and missed earnings estimates by -$.05.
In the last 3 years, RPID traded as high as $4.94 and as low as $.58.
The top ETF exchange traded funds that RPID belongs to (by Net Assets): VTI, VXF, IWC, DFMC, DFAS.
RPID has underperformed the market in the last year with a price return of -6.3% while the SPY ETF gained +36.0%. RPID has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -46.2% and -0.9%, respectively, while the SPY returned +2.7% and +8.1%, respectively.
RPID support price is $2.14 and resistance is $2.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RPID shares will trade within this expected range on the day.